Neovasc Inc. – Consensus Indicates Potential 116.1% Upside

Broker Ratings

Neovasc Inc. found using ticker (NVCN) have now 2 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 2.25 and 1.5 calculating the mean target price we have 1.88. Now with the previous closing price of 0.87 this would imply there is a potential upside of 116.1%. There is a 50 day moving average of 0.82 while the 200 day moving average is 1.93. The market cap for the company is $24m. You can visit the company’s website by visiting: http://www.neovasc.com

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index